Stockreport

Blueprint Medicines Stock Jumps on Rise in Ayvakit Sales [MarketWatch]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF The stock rose 15% to $88.38. Shares are up 100% over the past 12 months. Advertisement The Cambridge, Mass.-based precision therapy company on Thursday said it ach [Read more]